Abstract
Numerous casein and whey protein-derived angiotensin-I-converting enzyme (ACE) inhibitory peptides/hydrolysates have been identified. Clinical trials in hypertensive animals and humans show that these peptides/hydrolysates can bring about a significant reduction in hypertension. These peptides/hydrolysates may be classified as functional food ingredients and nutraceuticals due to their ability to provide health benefits i.e. as functional food ingredients in reducing the risk of developing a disease and as nutraceuticals in the prevention/treatment of disease.
Original language | English |
---|---|
Pages (from-to) | S33-S37 |
Journal | British Journal of Nutrition |
Volume | 84 |
Issue number | SUPPL. 1 |
DOIs | |
Publication status | Published - 2000 |